|
1
|
Chou CT, Yang JS and Lee MR: Apoptosis in
rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in
rheumatoid synovial tissues. J Pathol. 193:110–116. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tak PP, Zvaifler NJ, Green DR and
Firestein GS: Rheumatoid arthritis and p53: how oxidative stress
might alter the course of inflammatory diseases. Immunol Today.
21:78–82. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamanishi Y, Boyle DL, Rosengren S, Green
DR, Zvaifler NJ and Firestein GS: Regional analysis of p53
mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA.
99:10025–10030. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayashi S, Miura Y, Nishiyama T, et al:
Decoy receptor 3 expressed in rheumatoid synovial fibroblasts
protects the cells against Fas-induced apoptosis. Arthritis Rheum.
56:1067–1075. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pitti RM, Marsters SA, Lawrence DA, et al:
Genomic amplification of a decoy receptor for Fas ligand in lung
and colon cancer. Nature. 396:699–703. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bai C, Connolly B, Metzker ML, et al:
Overexpression of M68/DcR3 in human gastrointestinal tract tumors
independent of gene amplification and its location in a four-gene
cluster. Proc Natl Acad Sci USA. 97:1230–1235. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohshima K, Haraoka S, Sugihara M, et al:
Amplification and expression of a decoy receptor for fas ligand
(DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett.
160:89–97. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Zhang L and Kim S: Quantification
and detection of DcR3, a decoy receptor in TNFR family. J Immunol
Methods. 285:63–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi G, Wu Y, Zhang J and Wu J: Death decoy
receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.
J Immunol. 171:3407–3414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsuji S, Hosotani R, Yonehara S, et al:
Endogenous decoy receptor 3 blocks the growth inhibition signals
mediated by Fas ligand in human pancreatic adenocarcinoma. Int J
Cancer. 106:17–25. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and
Kwon BS: A newly identified member of tumor necrosis factor
receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J
Biol Chem. 274:13733–13736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Migone TS, Zhang J, Luo X, et al: TL1A is
a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell
costimulator. Immunity. 16:479–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu
TL and Lin WW: Decoy receptor 3 (DcR3) induces osteoclast formation
from monocyte/macrophage lineage precursor cells. Cell Death
Differ. 11(Suppl 1): S97–S107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu MJ, Lin WW, Tsao WC, et al: Enhanced
adhesion of monocytes via reverse signaling triggered by decoy
receptor 3. Exp Cell Res. 292:241–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tateishi K, Miura Y, Hayashi S, Takahashi
M and Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by
increasing integrin alpha4. Biochem Biophys Res Commun.
389:593–598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi M, Miura Y, Hayashi S, Tateishi
K, Fukuda K and Kurosaka M: DcR3-TL1A signalling inhibits
cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Int J Mol Med. 28:423–427. 2011.PubMed/NCBI
|
|
17
|
Arnett FC, Edworthy SM, Bloch DA, et al:
The American Rheumatism Association 1987 revised criteria for the
classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamada N, Hisamatsu T, Honda H, et al:
TL1A produced by lamina propria macrophages induces Th1 and Th17
immune responses in cooperation with IL-23 in patients with Crohn’s
disease. Inflamm Bowel Dis. 16:568–575. 2010.PubMed/NCBI
|
|
19
|
Bamias G, Martin C III, Marini M, et al:
Expression, localization, and functional activity of TL1A, a novel
Th1-polarizing cytokine in inflammatory bowel disease. J Immunol.
171:4868–4874. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prehn JL, Mehdizadeh S, Landers CJ, et al:
Potential role for TL1A, the new TNF-family member and potent
costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol.
112:66–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Papadakis KA, Zhu D, Prehn JL, et al:
Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced
IFN-gamma production by peripheral blood and mucosal
CCR9+ T lymphocytes. J Immunol. 174:4985–4990. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cassatella MA, Pereira-da-Silva G, Tinazzi
I, et al: Soluble TNF-like cytokine (TL1A) production by immune
complexes stimulated monocytes in rheumatoid arthritis. J Immunol.
178:7325–7333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prehn JL, Thomas LS, Landers CJ, Yu QT,
Michelsen KS and Targan SR: The T cell costimulator TL1A is induced
by FcgammaR signaling in human monocytes and dendritic cells. J
Immunol. 178:4033–4038. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Wang X, Fahmi H, et al: Role of
TL1A in the pathogenesis of rheumatoid arthritis. J Immunol.
183:5350–5357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sethi G, Sung B and Aggarwal BB:
Therapeutic potential of VEGI/TL1A in autoimmunity and cancer. Adv
Exp Med Biol. 647:207–215. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bamias G, Siakavellas S, Stamatelopoulos
K, Chryssochoou E, Papamichael C and Sfikakis P: Circulating levels
of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in
rheumatoid arthritis. Clin Immunol. 129:249–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Edwards JR, Sun SG, Locklin R, et al:
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated
in rheumatoid arthritis. Arthritis Rheum. 54:1451–1462. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khan J, Simon R, Bittner M, et al: Gene
expression profiling of alveolar rhabdomyosarcoma with cDNA
microarrays. Cancer Res. 58:5009–5013. 1998.PubMed/NCBI
|
|
29
|
Espinosa I, Catasus L, Canet B, D’Angelo
E, Munoz J and Prat J: Gene expression analysis identifies two
groups of ovarian high-grade serous carcinomas with different
prognosis. Mod Pathol. 24:846–854. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang YC, Chen TC, Lee CT, et al:
Epigenetic control of MHC class II expression in tumor-associated
macrophages by decoy receptor 3. Blood. 111:5054–5063. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Yang S, Lu S, et al: Differential
gene expression profile associated with the abnormality of bone
marrow mesenchymal stem cells in aplastic anemia. PLoS One.
7:e477642012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Whitney LW, Becker KG, Tresser NJ, et al:
Analysis of gene expression in mutiple sclerosis lesions using cDNA
microarrays. Ann Neurol. 46:425–428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heller RA, Schena M, Chai A, et al:
Discovery and analysis of inflammatory disease-related genes using
cDNA microarrays. Proc Natl Acad Sci USA. 94:2150–2155. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee SK, Jeon EK, Kim YJ, et al: A global
gene expression analysis of the peripheral blood mononuclear cells
reveals the gene expression signature in psoriasis. Ann Dermatol.
21:237–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van der Pouw Kraan TC, van Gaalen FA,
Kasperkovitz PV, et al: Rheumatoid arthritis is a heterogeneous
disease: evidence for differences in the activation of the STAT-1
pathway between rheumatoid tissues. Arthritis Rheum. 48:2132–2145.
2003.PubMed/NCBI
|
|
36
|
Akitaya T and Bronner-Fraser M: Expression
of cell adhesion molecules during initiation and cessation of
neural crest cell migration. Dev Dyn. 194:12–20. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kashima T, Nakamura K, Kawaguchi J, et al:
Overexpression of cadherins suppresses pulmonary metastasis of
osteosarcoma in vivo. Int J Cancer. 104:147–154. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marie PJ: Role of N-cadherin in bone
formation. J Cell Physiol. 190:297–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nonomura Y, Mizoguchi F, Suzuki A, et al:
Hypoxia-induced abrogation of contact-dependent inhibition of
rheumatoid arthritis synovial fibroblast proliferation. J
Rheumatol. 36:698–705. 2009. View Article : Google Scholar
|
|
40
|
Hasko G and Szabo C: IL-12 as a
therapeutic target for pharmacological modulation in
immune-mediated and inflammatory diseases: regulation of T helper
1/T helper 2 responses. Br J Pharmacol. 127:1295–1304. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Paradowska-Gorycka A, Grzybowska-Kowalczyk
A, Wojtecka-Lukasik E and Maslinski S: IL-23 in the pathogenesis of
rheumatoid arthritis. Scand J Immunol. 71:134–145. 2010. View Article : Google Scholar
|
|
42
|
Swaak AJ, van den Brink HG and Aarden LA:
Cytokine production in whole blood cell cultures of patients with
rheumatoid arthritis. Ann Rheum Dis. 56:693–695. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu FL, Chen CH, Chu SJ, et al:
Interleukin (IL)-23 p19 expression induced by IL-1beta in human
fibroblast-like synoviocytes with rheumatoid arthritis via active
nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology
(Oxford). 46:1266–1273. 2007. View Article : Google Scholar
|
|
44
|
Kim HR, Cho ML, Kim KW, et al:
Up-regulation of IL-23p19 expression in rheumatoid arthritis
synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and
p38 MAPK-dependent signalling pathways. Rheumatology (Oxford).
46:57–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kular L, Pakradouni J, Kitabgi P, Laurent
M and Martinerie C: The CCN family: a new class of inflammation
modulators? Biochimie. 93:377–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yadav VK and Ducy P: Lrp5 and bone
formation. Ann NY Acad Sci. 1192:103–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gustafsson BI, Thommesen L, Stunes AK, et
al: Serotonin and fluoxetine modulate bone cell function in vitro.
J Cell Biochem. 98:139–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ducy P and Karsenty G: The two faces of
serotonin in bone biology. J Cell Biol. 191:7–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Andersen JS, Wilkinson CJ, Mayor T,
Mortensen P, Nigg EA and Mann M: Proteomic characterization of the
human centrosome by protein correlation profiling. Nature.
426:570–574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Doxsey S, Zimmerman W and Mikule K:
Centrosome control of the cell cycle. Trends Cell Biol. 15:303–311.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shi X, Sun X, Liu M, Li D, Aneja R and
Zhou J: CEP70 protein interacts with gamma-tubulin to localize at
the centrosome and is critical for mitotic spindle assembly. J Biol
Chem. 286:33401–33408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi X, Wang J, Yang Y, Ren Y, Zhou J and
Li D: Cep70 promotes microtubule assembly in vitro by increasing
microtubule elongation. Acta Biochim Biophys Sin (Shanghai).
44:450–454. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Leon O and Roth M: Zinc fingers: DNA
binding and protein-protein interactions. Biol Res. 33:21–30. 2000.
View Article : Google Scholar : PubMed/NCBI
|
